source
- BrainChild Bio raises $116 million to fund pivotal pediatric brain tumor CAR-T trialBrainChild Bio, a Seattle-based biotech, announced it has secured $116 million in financing to support a pivotal clinical trial of its CAR-T therapy aimed at pediatric brain tumors. The funding ro…
- Diabetes cell-therapy firms Sernova and Seraxis announce mergerTwo diabetes-focused cell-therapy companies, Sernova and Seraxis, have agreed to merge after decades of developing treatments for the disease. The combined company aims to pool resources and exper…